Overview:

Our client is a rapidly growing oncology-focused biotech company advancing innovative immuno-oncology therapies. They are seeking an experienced and visionary Chief Medical Officer to lead our clinical development and medical strategy, driving the development of our portfolio toward regulatory approval and commercialization.

Key Responsibilities:

• Strategic Leadership: Develop and oversee the company’s medical and clinical strategy, ensuring alignment with corporate objectives and pipeline priorities.
• Clinical Development: Lead the design, execution, and oversight of clinical trials, with a focus on advancing immuno-oncology therapies. Ensure robust clinical development plans that meet regulatory, scientific, and ethical standards.
• Regulatory Engagement: Serve as the primary medical interface with global regulatory authorities, guiding interactions to support clinical development and approval processes.
• Cross-Functional Collaboration: Work closely with research, regulatory, commercial, and executive teams to integrate clinical insights into strategic decision-making.
• External Representation: Represent the company in scientific, medical, and investor forums, articulating the medical and clinical value of the pipeline.
• Team Leadership: Build, mentor, and manage a high-performing medical team to support the company's clinical and regulatory objectives.

Qualifications:

• MD or equivalent medical degree with board certification in oncology or hematology strongly preferred.
• Proven track record of leadership in immuno-oncology, including successful clinical trial design and execution in biotech, pharmaceutical, or related sectors.
• Experience in a publicly traded company, with demonstrated ability to engage with investors, analysts, and external stakeholders.
• Comprehensive understanding of the regulatory landscape for oncology drug development.
• Strong interpersonal and communication skills, with the ability to collaborate effectively across diverse teams and external partners.

Preferred Experience:

• Demonstrated success in advancing oncology therapies from early development through regulatory approval.
• Expertise in biomarkers, combination therapies, and next-generation immuno-oncology platforms.
• Deep understanding of the competitive oncology landscape, including trends and emerging science.